PL4426307T3 - Nowa doustna kompozycja farmaceutyczna i schemat dawkowania w terapii postępujących włókniejących śródmiąższowych chorób płuc - Google Patents

Nowa doustna kompozycja farmaceutyczna i schemat dawkowania w terapii postępujących włókniejących śródmiąższowych chorób płuc

Info

Publication number
PL4426307T3
PL4426307T3 PL22835249.8T PL22835249T PL4426307T3 PL 4426307 T3 PL4426307 T3 PL 4426307T3 PL 22835249 T PL22835249 T PL 22835249T PL 4426307 T3 PL4426307 T3 PL 4426307T3
Authority
PL
Poland
Prior art keywords
therapy
pharmaceutical composition
oral pharmaceutical
interstitial lung
lung diseases
Prior art date
Application number
PL22835249.8T
Other languages
English (en)
Inventor
Christian Hesslinger
Verena BAUER
Sebastian Martin BOSSERT
Peter Nickolaus
Susan KOBER
Yi Liu
Maria Sarno
Florian Voss
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=84785289&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL4426307(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of PL4426307T3 publication Critical patent/PL4426307T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
PL22835249.8T 2021-12-09 2022-12-08 Nowa doustna kompozycja farmaceutyczna i schemat dawkowania w terapii postępujących włókniejących śródmiąższowych chorób płuc PL4426307T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202163287642P 2021-12-09 2021-12-09
EP21218202 2021-12-29
EP22177750 2022-06-08
PCT/EP2022/084968 WO2023104958A1 (en) 2021-12-09 2022-12-08 New oral pharmaceutical composition and dose regimen for the therapy of progressive fibrosing interstitial lung diseases

Publications (1)

Publication Number Publication Date
PL4426307T3 true PL4426307T3 (pl) 2025-11-17

Family

ID=84785289

Family Applications (1)

Application Number Title Priority Date Filing Date
PL22835249.8T PL4426307T3 (pl) 2021-12-09 2022-12-08 Nowa doustna kompozycja farmaceutyczna i schemat dawkowania w terapii postępujących włókniejących śródmiąższowych chorób płuc

Country Status (20)

Country Link
US (2) US20230181590A1 (pl)
EP (2) EP4494700A3 (pl)
JP (1) JP2024543161A (pl)
KR (2) KR20260004530A (pl)
AU (2) AU2022407131C1 (pl)
CA (1) CA3234847A1 (pl)
CL (2) CL2024001520A1 (pl)
DK (1) DK4426307T3 (pl)
ES (1) ES3041145T3 (pl)
FI (1) FI4426307T3 (pl)
HR (1) HRP20251043T1 (pl)
HU (1) HUE073199T2 (pl)
IL (1) IL312740A (pl)
LT (1) LT4426307T (pl)
MX (1) MX2024006270A (pl)
PL (1) PL4426307T3 (pl)
RS (1) RS67225B1 (pl)
SI (1) SI4426307T1 (pl)
TW (2) TW202617156A (pl)
WO (1) WO2023104958A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025528779A (ja) * 2022-08-09 2025-09-02 シーザン ハイスーク ファーマシューティカル カンパニー リミテッド Ｐｄｅ４ｂ阻害剤及びその用途
WO2026125461A1 (en) * 2024-12-12 2026-06-18 Boehringer Ingelheim International Gmbh Method of manufacturing a pharmaceutical composition comprising nerandomilast
WO2026125454A1 (en) * 2024-12-12 2026-06-18 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising nerandomilast
CN119857088A (zh) * 2025-01-22 2025-04-22 杭州畅溪制药有限公司 复方吸入粉雾剂及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004057618A1 (de) 2004-11-29 2006-06-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen
DE102004057645A1 (de) 2004-11-29 2006-06-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen
DE102004057594A1 (de) 2004-11-29 2006-06-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substitueirte Pteridine zur Behandlung von entzündlichen Erkrankungen
DE102004057595A1 (de) 2004-11-29 2006-06-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen
EP1847543A1 (de) 2006-04-19 2007-10-24 Boehringer Ingelheim Pharma GmbH & Co. KG Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
HRP20090395T1 (hr) 2006-04-19 2009-08-31 Boehringer Ingelheim International Gmbh Dihidrotienpirimidini za liječenje upalnih bolesti
RU2500681C2 (ru) 2007-10-19 2013-12-10 Берингер Ингельхайм Интернациональ Гмбх Замещенные гетероциклом пиперазинодигидротиенопиримидины
SI2610258T1 (sl) 2007-10-19 2014-12-31 Boehringer Ingelheim International Gmbh Substituirani piperidino-dihidrotienopirimidini
US20130059866A1 (en) * 2011-08-24 2013-03-07 Boehringer Ingelheim International Gmbh Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
LT3700529T (lt) * 2017-10-23 2025-10-10 Naujas veikliųjų medžiagų derinys, skirtas progresuojančių fibrozinių intersticinių plaučių ligų (pf-ild) gydymui

Also Published As

Publication number Publication date
EP4494700A3 (en) 2025-04-16
SI4426307T1 (sl) 2025-12-31
EP4494700A2 (en) 2025-01-22
HUE073199T2 (hu) 2026-01-28
EP4426307A1 (en) 2024-09-11
CL2024001520A1 (es) 2024-11-22
TW202339731A (zh) 2023-10-16
MX2024006270A (es) 2024-06-11
CA3234847A1 (en) 2023-06-15
ES3041145T3 (en) 2025-11-07
RS67225B1 (sr) 2025-10-31
HRP20251043T1 (hr) 2025-10-24
AU2022407131C1 (en) 2025-10-30
DK4426307T3 (da) 2025-09-15
EP4426307B1 (en) 2025-07-02
IL312740A (en) 2024-07-01
FI4426307T3 (fi) 2025-09-10
JP2024543161A (ja) 2024-11-19
TW202617156A (zh) 2026-05-01
KR20260004530A (ko) 2026-01-08
CL2024003616A1 (es) 2025-03-21
AU2025205402A1 (en) 2025-07-31
LT4426307T (lt) 2025-09-10
US20230181590A1 (en) 2023-06-15
WO2023104958A1 (en) 2023-06-15
AU2022407131B2 (en) 2025-06-19
US20250025466A1 (en) 2025-01-23
KR20240121251A (ko) 2024-08-08
AU2022407131A1 (en) 2024-04-11

Similar Documents

Publication Publication Date Title
AU2022407131B2 (en) New oral pharmaceutical composition and dose regimen for the therapy of progressive fibrosing interstitial lung diseases
IL216468B (en) Pharmaceutical compositions deliverable from a metered dose inhaler comprising glycopyrrolate and formoterol and their use in treatment of pulmonary diseases
PH12016500619A1 (en) Dry powder inhaler
PH12020551911A1 (en) Use of riluzole oral disintigrating tablets for treating diseases
ES3066432T3 (en) New therapeutic combinations comprising pirfenidone and pde4-inhibitor for the treatment of progressive fibrosing interstitial lung diseases
JP2017506624A5 (pl)
MX2014013039A (es) Uso de laquinimod de dosis alta para el tratamiento de esclerosis multiple.
WO2012040228A3 (en) Aerosol composition for administering drugs
MX2024007642A (es) Uso de tabletas de desintegracion oral de riluzol para tratar enfermedades.
JOP20200015A1 (ar) توليفة علاجية من مثبط كيناز تيروسين egfr من الجيل الثالث ومثبط كيناز يعتمد على سيكلين
MD4369B1 (ro) Utilizarea glicopirolatului pentru tratarea tahicardiei, doză unică, dispozitiv de administrare, metodă de tratament şi profilaxie a tahicardiei
PH12015502465A1 (en) Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias
PL3956001T3 (pl) Urządzenie do jednoczesnego podawania tlenu i leków z inhalatora z odmierzaną dawką przez inhalację
NO20044498L (no) Kombinasjonsterapi for behandling av cancer
PL4188327T3 (pl) Terapia skojarzona do podawania wziewnego
MX2018005298A (es) Regimen de dosificacion para un inhibidor de fosfatidilinositol 3-quinasa.
PT4426307T (pt) Nova composição farmacêutica oral e regime de dosagem para a terapia de doenças pulmonares intersticiais fibrosantes progressivas
BR112014004339A2 (pt) suspensão oral
WO2016122288A3 (ko) 베르베논 유도체 및 재관류 치료제를 포함하는 뇌혈관 질환, 동맥경화증 또는 심혈관 질환 치료 또는 예방용 병용 제제
JP2016504361A5 (pl)
PH12021550656A1 (en) Methods for reducing the risk of diabetes in patients being treated for high cholesterol-related illnesses
ATE409039T1 (de) Kombinationstherapie gegen krebserkrankungen mit azd2171 und zd1839
MX2021007324A (es) Terapia oral con acido 6,8-bis-benciltio-octanoico.
MX2024013342A (es) Metodo y composicion para el tratamiento de enfermedades pulmonares
MX2021014343A (es) Una composicion de polvo inhalable de dosis fijas que comprende glicopirronio, formoterol y propionato de fluticasona.